Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

Abstract Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Xindi Zhang, Matthew R. Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C. Dinh, Megan M. Shuey, Regeneron Genetics Center, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Robert Huddart, Neil E. Martin, Victoria A. Sanchez, Robert D. Frisina, Lawrence H. Einhorn, Nancy J. Cox, Lois B. Travis, M. Eileen Dolan
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Wiley 2022-07-01
Sarja:Cancer Medicine
Aiheet:
cisplatin
GWAS
ototoxicity
survivorship
neurotoxicity
testicular cancer
Linkit:https://doi.org/10.1002/cam4.4644

Internet

https://doi.org/10.1002/cam4.4644

Samankaltaisia teoksia